Global Drug Device Combination Products Market $128 Billion by 2021

According to a market research report Drug Device Combination Products Market Analysis and Forecast 2017-2021 published by iHealthcareAnalyst, Inc., the global drug device combination products market is estimated to reach $128 Billion in 2021, expanding at a CAGR of 6.6% from 2017 to 2021.

The global drug device combination products market segmentation is based on device types (drug eluting stents, coronary stents, peripheral vascular stents, infusion pumps, implantable infusion pumps, ambulatory infusion pumps, photosensitizers, orthopedic combination products, antibiotic bone cement, bone graft implants, wound care combination products, antibiotic wound care products, inhalers, nebulizers, metered dose inhalers, dry powder inhalers, transdermal patches, intraocular implants, drug eluting beads).

The global drug device combination products market report provides market size (Revenue $Million 2014 to 2021), market share, market trends and forecasts growth trends (CAGR%, 2017 to 2021). The global drug device combination products market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

Visit the Drug Device Combination Products Market Analysis and Forecast 2017-2021 report at https://www.ihealthcareanalyst.com/report/drug-device-combination-products-market/

1. Device Type
1.1 Drug Eluting Stents
1.1.1 Coronary stents
1.1.2 Peripheral Vascular Stents
1.2 Infusion Pumps
1.2.1 Implantable Infusion Pumps
1.2.2 Ambulatory Infusion Pump
1.3 Photosensitizers
1.4 Orthopedic Combination Products
1.4.1 Antibiotic Bone Cement
1.4.2 Bone Graft Implants
1.5 Wound Care Combination Products
1.5.1 Antibiotic Wound Care Products
1.6 Inhalers
1.6.1 Nebulizers
1.6.2 Metered Dose Inhalers
1.6.3 Dry Powder Inhalers
1.7 Transdermal Patches
1.8 Others (Intraocular Implants, Drug Eluting Beads, etc.)

2. Geography (Region, Country)
2.1 North America (U.S., Canada)
2.2 Latin America (Brazil, Mexico, Rest of LA)
2.3 Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
2.4 Asia Pacific (Japan, China, India, Rest of APAC)
2.5 Rest of the World

3. Company Profiles
3.1 Abbott Laboratories
3.2 Allergan, Inc.
3.3 Alcon, Inc.
3.4 Arrow International, Inc.
3.5 Bausch & Lomb, Inc.
3.6 Boston Scientific Corporation
3.7 CareFusion Corporation
3.8 Covidien PLC
3.9 C.R. Bard, Inc.
3.10 Ethicon, Inc.
3.11 Medline Industries, Inc.
3.13 Medtronic, Inc.
3.14 Mylan, Inc.
3.15 Pinnacle Biologics, Inc.
3.16 Stryker Corporation
3.17 Terumo Corporation
3.18 W.L. Gore & Associates, Inc.

To request Table of Contents and Sample Pages of this report visit:
https://www.ihealthcareanalyst.com/report/drug-device-combination-products-market/

iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare IT, healthcare services, medical devices, medical equipment, and pharmaceuticals.

In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.

Ana Aitawa
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareanalyst.com
https://www.ihealthcareanalyst.com

This release was published on openPR.